科伦药业: insider trades · France · AMF SZSE:002422 FR FR · AMF Mcap 46.9Bn€
Discover the full management transaction log of 科伦药业, a publicly traded company based in France. Shares are quoted on FR FR, under the authority of AMF. Market capitalisation: €46.9bn. The latest transaction was filed on 12 April 2022 — Purchase. Among the most active insiders: 刘思川. Every trade is accessible without an account.
Financial data FY ended December 2025 · cache
Income statement
Revenue 18.51 Bn€
Gross profit 8.86 Bn€ 48% margin
Net income 1.70 Bn€ 9.2% margin
Balance sheet & cash
Market cap 46.90 Bn€
Total debt 3.50 Bn€
Free Cash Flow 1.02 Bn€
Last declaration on 12 April 2022
Declarations 7 total
Executives ● Purchase10 SZSE
100,000 shares
SZSE:173000005428776300 · 12 Apr 2022
Ideal exit: 7 Jan 2023 (T+270) Executives ● Purchase10 SZSE
100,000 shares
SZSE:173000004565785400 · 15 Jul 2021
Ideal exit: 11 Apr 2022 (T+270) Executives ● Purchase25 SZSE
100,000 shares
SZSE:173000004560250750 · 13 Jul 2021
Ideal exit: 9 Apr 2022 (T+270) Executives ● Purchase22 SZSE
50,000 shares
SZSE:173000004549240350 · 8 Jul 2021
Ideal exit: 4 Apr 2022 (T+270) Executives ● Purchase22 SZSE
10,000 shares
SZSE:173000005429993660 · 2 Jul 2021
Ideal exit: 29 Mar 2022 (T+270) Executives ● Purchase22 SZSE
253,900 shares
SZSE:173000004537262750 · 2 Jul 2021
Ideal exit: 29 Mar 2022 (T+270) Executives ● Purchase22 SZSE
20,000 shares
SZSE:173000005429992400 · 2 Jul 2021
Ideal exit: 29 Mar 2022 (T+270)